Search results
Results from the WOW.Com Content Network
Asherman's syndrome (AS) is an acquired uterine condition that occurs when scar tissue forms inside the uterus and/or the cervix. [1] It is characterized by variable scarring inside the uterine cavity, where in many cases the front and back walls of the uterus stick to one another.
Asherman's syndrome [48] Implantation failure without any known primary cause. It results in negative pregnancy test despite having performed e.g. embryo transfer. Myomas; Previously, a bicornuate uterus was thought to be associated with infertility, [49] but recent studies have not confirmed such an association. [50]
Asherman has published dozens of medical articles. Among other things, he described a syndrome that bears his name, Asherman's Syndrome, which includes scarring and infection in the uterus due to curettage, which was first described by a German doctor ( Heinrich Fritsch ) in 1894 but was characterized following two articles by Asherman in 1948 ...
An eponymous disease is a disease, disorder, condition, or syndrome named after a person, usually the physician or other health care professional who first identified the disease; less commonly, a patient who had the disease; rarely, a literary character who exhibited signs of the disease or an actor or subject of an allusion, as characteristics associated with them were suggestive of symptoms ...
An important risk factor for placenta accreta is placenta previa in the presence of a uterine scar. Placenta previa is an independent risk factor for placenta accreta. Additional reported risk factors for placenta accreta include maternal age and multiparity, other prior uterine surgery, prior uterine curettage, uterine irradiation, endometrial ablation, Asherman syndrome, uterine leiomyomata ...
It encompasses a variety of reproductive conditions, their prevention and assessment, as well as their subsequent treatment and prognosis. Reproductive medicine has allowed the development of artificial reproductive techniques (ARTs) which have allowed advances in overcoming human infertility , as well as being used in agriculture and in ...
However, if no bleeding occurs after progesterone withdrawal, then the patient's amenorrhea is likely to be due to either a) low serum estradiol (i.e. premature ovarian failure), b) hypothalamic-pituitary axis dysfunction (such as low GNRH or low FSH that lead to low estrogen level ), c) a nonreactive endometrium, or d) a problem with the ...
"Outcomes From Treatment of Infertility With Natural Procreative Technology in an Irish General Practice". The Journal of the American Board of Family Medicine. 21 (5): 375– 84. doi: 10.3122/jabfm.2008.05.070239. hdl: 10379/13999. PMID 18772291. Hilgers, TW; Stanford, JB (1998). "Creighton Model NaProEducation Technology for avoiding pregnancy.